These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18307224

  • 1. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
    Wood FO, Saylors EK, Schneider JE, Jobe RL, Mann JT.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):533-8. PubMed ID: 18307224
    [Abstract] [Full Text] [Related]

  • 2. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2008 Apr 01; 71(5):594-8. PubMed ID: 18311841
    [Abstract] [Full Text] [Related]

  • 3. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):539-40. PubMed ID: 18307235
    [No Abstract] [Full Text] [Related]

  • 4. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ.
    J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467
    [Abstract] [Full Text] [Related]

  • 5. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
    Akin I, Bufe A, Eckardt L, Reinecke H, Richardt G, Kuck KH, Senges J, Schneider S, Nienaber CA, DES.DE Study Group.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):50-7. PubMed ID: 20578192
    [Abstract] [Full Text] [Related]

  • 6. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):448-56. PubMed ID: 18814218
    [Abstract] [Full Text] [Related]

  • 7. Acute and long-term outcome of unprotected left main coronary angioplasty compared to the anticipated surgical risk.
    Rademacher W, Knape A, Schumm J, Ferrari M, Lauten A, Mudra H, Figulla HR.
    Interact Cardiovasc Thorac Surg; 2008 Oct 01; 7(5):871-7. PubMed ID: 18603543
    [Abstract] [Full Text] [Related]

  • 8. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
    Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R.
    Catheter Cardiovasc Interv; 2006 Jul 01; 68(1):62-6. PubMed ID: 16755592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results.
    Sheiban I, Ballari GP, Moretti C, Marra WG, Meliga E, Omedè P, Sciuto F, Trevi GP.
    J Cardiovasc Med (Hagerstown); 2007 Aug 01; 8(8):582-8. PubMed ID: 17667028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK, Ronan A, Cohoon K, Homan D, Sutherland J, Steen L, Liu J, Loeb H, Lewis BE.
    Catheter Cardiovasc Interv; 2008 Jun 01; 71(7):886-93. PubMed ID: 18412238
    [Abstract] [Full Text] [Related]

  • 14. Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome.
    Lehmann R, Spyridopoulos I, Kremer J, Zeiher AM, Schächinger V, Fichtlscherer S.
    J Interv Cardiol; 2009 Aug 01; 22(4):311-9. PubMed ID: 19689656
    [Abstract] [Full Text] [Related]

  • 15. Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).
    Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Marra S, Moretti C, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW.
    Int J Cardiol; 2009 Sep 11; 137(1):16-21. PubMed ID: 18687481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: the TAXi-LATE trial.
    Berger A, Stauffer JC, Seydoux C, Siegenthaler M, Benoît A, Goy JJ.
    Catheter Cardiovasc Interv; 2007 Aug 01; 70(2):163-6. PubMed ID: 17630653
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.